EP3473629A1 — Method for producing substituted polycyclic pyridone derivative and crystal of same
Assigned to Shionogi and Co Ltd · Expires 2019-04-24 · 7y expired
What this patent protects
The present invention provides a process for preparing a compound of the formula (II): wherein R 2 is unsubstituted alkyl, characterized by reacting a compound of the formula (I): wherein R 1 is hydrogen or a protecting group other than unsubstituted alkyl, with a compo…
USPTO Abstract
The present invention provides a process for preparing a compound of the formula (II): wherein R 2 is unsubstituted alkyl, characterized by reacting a compound of the formula (I): wherein R 1 is hydrogen or a protecting group other than unsubstituted alkyl, with a compound of the formula: R 2 -OH, wherein R 2 is as defined above, in the presence of a sodium salt and/or a magnesium salt.
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.